Emerging evidence suggests that AIP demonstrates stronger predictive associations than individual lipid indices in certain clinical contexts, such as evaluating cardiovascular risk, insulin resistance, and skeletal muscle loss (25, 26), providing a robust theoretical basis for its clinical utility. The gene discussed is INS; the disease is autoimmune pancreatitis.